Tomáš Pluskal is a distinguished professional with a strong background in biotechnology and computer science. Currently serving as Co-Founder at mzio since February 2024, Pluskal also holds the position of Junior Group Leader at IOCB Prague - Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences since June 2020. Previous consulting roles include external consultancy at Ginkgo Bioworks, Inc. and Dialectica in 2021. Pluskal's academic journey includes postdoctoral research at the Whitehead Institute from 2015 to 2020 and a PhD in Molecular Biotechnology from Hiroshima University, complemented by an M.Sc. in Computer Science from Charles University. Further experience includes visiting scientist positions at various institutions and a teaching role in computer science.

Location

Prague, Czech Republic

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices


IOCB Prague - Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences

1 followers

The Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences (IOCB Prague) is a leading scientific institution in the Czech Republic, recognized internationally. Its primary mission is basic research in the fields of chemical biology and medicinal chemistry, organic and material oriented chemistry, chemistry of natural compounds, biochemistry and molecular biology, physical chemistry, theoretical chemistry, and analytical chemistry. Today, over 600 employees including 180 students in 45 research and service groups are involved in a broad spectra of disciplines, which results in more than 250 publications per year, including papers in the most cited prestigious journals such as Nature or Science. The Institute’s emphasis on interaction between chemistry and other sciences leads frequently to medicinal applications. An integral part of the mission of the Institute is, therefore, to transfer the scientific results into assets which help people to live better lives. Together with the research expertise, a system of technology transfer, IP management and commercialization have intensively been built-up. Through its subsidiary company IOCB TTO, the Institute helps scientists to transform ideas into patents and matches their research results with interests of commercial partners to bring novel ideas to human use or technology market.


Employees

501-1,000

Links